Table 1.
Patient demographics and baseline laboratory values
| Parameters | Value |
|---|---|
| Total patients (n) | 38 |
| Inadequate follow-up | 5 |
| Invalid scans (success < 60%) | 4 |
| Final analysis | 29 |
| Sex (male) | 23 (79%) |
| Age (years) | 44 (20–69) |
| HBeAg-positive | 16 (55%) |
| Bilirubin (μmol/L) | 34 (10–469) |
| Alkaline phosphatase (U/L) | 114 (56–220) |
| GGT (U/L) | 159 (48–540) |
| AST (U/L) | 524 (208–1,678) |
| ALT (U/L) | 1,464 (594–2,476) |
| Albumin (g/L) | 39 (27–46) |
| Prothrombin time (s) | 12.8 (11.1–24.6) |
| Platelets (109 L−1) | 185 (78–313) |
| HBV DNA (copies/mL) | 100,000,000 (646,020–640,000,000) |
| Liver stiffness measurement (kPa) | 16.8 (6.9–47.2) |
| Interquartile ratioa | 17% (4–47%) |
| <10 kPa | 7 (24%) |
| 10–20 kPa | 10 (35%) |
| >20 kPa | 12 (41%) |
Continuous variables expressed as median values
aInterquartile ratio = interquartile range/liver stiffness. Eighty-six percent of patients had ratio ≤30%